FAP-Ligand PET Update ≠ Cancer
Presented by: Professor Jeremie Calais, MD, MSc, Professor, University of California, Los Angeles
2022 Annual SNMMI […]
Fibroblast Activation Protein (FAP) – A promising target for radiopharmaceuticals
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
June 8, 2022 Download the Presentation […]
Pitfalls and Common Findings in 68 Ga-FAPI PET: A Pictorial Analysis
Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, […]
SOFIE Opens 20,000 sq ft Theranostics Center of Excellence
Dulles, VA, April 27, 2022– SOFIE Co. (SOFIE), a Theranostics company, commissions its new […]
Comparison of 68 Ga-FAPI PET/CT and 18 FDG PET/CT Modalities in Gastrointestinal System Malignancies with Peritoneal Involvement
Umut Elboga, Ertan Sahin, Tulay Kus, Yusuf Burak Cayirli, Gokmen Aktas, Merve […]
FAPI-PET Opens a New Window for Understanding of Immune-Mediated Inflammatory Diseases
Torsten Kuwert, Christian Schmidkonz, Olaf Prante, Georg Schett, Andreas Ramming
Abstract: In vivo […]
Comparison of 68 Ga-FAPI and 18 F-FDG PET/CT in the Evaluation of Advanced Lung Cancer
Lijuan Wang, Ganghua Tang, Kongzhen Hu, Xinran Liu, Wenlan Zhou, Hongsheng Li, […]
Neuroendocrine Tumor Imaging
Explore the latest advances and techniques in neuroendocrine tumor imaging with Dr. Robert Bridwell — […]
Head-to-head Intra-individual Comparison of [ 68 Ga]-FAPI and [ 18 F]-FDG PET/CT in Patients with Bladder Cancer
E Novruzov, K Dendl, H Ndlovu, P L Choyke, M Dabir, M […]